Dr. Stamm holds a PhD in molecular parasitology and a master’s degree in drug regulatory affairs from the University of Bonn, Germany. He joined Charles River (formerly NewLab) in 2003 and became responsible for the business development activities in Europe, Asia, and the US.
Prior to joining Charles River/NewLab, he worked for Eurofins Scientific running their microbiological GMP testing laboratories in Switzerland. Most recently, Dr. Stamm has focused his work on business development activities and analytical/regulatory consulting for us in SE-Asia, Korea, India, and China and the development and commercialization of the Charles River’s first host cell protein kit.
Next Generation Sequencing in Adventitious Agent Testing: Navigating Regulatory Acceptance
In this webinar, Charles River biologics experts answer frequently asked questions about the use of NGS as an adventitious virus assay, from its utility in the lab to regulatory requirements.
Watch Webinar Replay